From The New York Times:
Drug advertising will face hard scrutiny in the new Congress as it considers the renewal of fees that manufacturers pay to speed reviews of new drugs. Read the article (free with registration) here.
Side effects of new Congress may include less advertising.
January 22, 2007 · No Comments
Categories: National news
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment